Values and tradition
Discover the HARTMANN DNA
Our work builds on a strong set of values, which we take seriously. Learn what we believe in, how it all began, and where we are now.
Learn more
Leadership is something we take seriously at the HARTMANN GROUP. PAUL HARTMANN AG and its functional areas manage the Group’s activities. We are committed to creating innovative solutions that will continue to improve healthcare and benefit both professionals and patients all over the world. Our management board brings a modern, forward-thinking approach to the business to set the agenda for the future of healthcare.
Meet our Management Board
Britta Fünfstück
Chairman of the Management Board (CEO)
Physicist Britta Fünfstück is the head of the HARTMANN GROUP. She is responsible for corporate strategy, the Transformation Program office, the Infection Management segment with the Risk Prevention and Disinfection divisions and the Kneipp subsidiary. Her responsibilities also include the German domestic market as well as the Pharmacy business, Digital, Human Resources, Communications, Quality Management and Compliance.
François Georgelin
Member of the Management Board
Biomedical engineer François Georgelin is responsible for the Wound Care segment, Regulatory Affairs and the KOB subsidiary. He is also in charge of commercial operations for Northern and Eastern Europe along with France, South America and the USA.
Stefan Grote
Member of the Management Board
Business economist Stefan Grote is responsible for the Incontinence Management segment along with the areas of Procurement, Supply Chain, Real Estate, Sustainability, Online and E-Commerce. He also manages commercial operations in Western and Southern Europe, Asia, Australia, the Middle East and Africa.
Oliver Neubrand
Member of the Management Board (CFO)
Business graduate Oliver Neubrand took over as CFO on January 1, 2024, and is responsible for Controlling, Finance, Accounting, Mergers & Acquisitions, Internal Audit, Risk Management, Legal, IT, Investor Relations as well as the CMC subsidiary and IVF HARTMANN business activities in Switzerland.
Meet our Supervisory Board
Our Supervisory Board, with its equal representation of employees and shareholders, oversees the Management Board and appoints its members.
Fritz-Jürgen Heckmann
Chairman of the Supervisory Board
Attorney-at-law in the lawyer co-partnership Kees Hehl Heckmann
Tobias Bucher*
Deputy Chairman of the Supervisory Board (from April 28, 2023)
Chief Authorized Representative of IG Metall Heidenheim
Yvonne Brix*
Emyployee Product Development Bode Chemie GmbH
Member of the Works Council of Bode Chemie GmbH (until April 28, 2023)
Prof. Dr. Angelika C. Bullinger-Hoffmann
Professor of Ergonomics and Innovation Management at Chemnitz University of Technology
Christine Geppert*
Full-time Chairwoman of the Works Council of KOB GmbH
Dr. Sidonie Golombowski-Daffner
President Advanced Accelerator Applications, Novartis (until December 31, 2023)
Independent consultant (from January 1, 2024) (from April 28, 2023)
Birgit Herm-Grimm*
Full-time Chairwoman of the Works Council of PAUL HARTMANN AG (until April 28, 2023)
Gerhard Hirth
Independent business consultant (until April 28, 2023)
Katja Kollosche*
Full-time Chairwoman of the Group Works Council of PAUL HARTMANN AG (from April 28, 2023)
Horst Mund*
Deputy Chairman of the Supervisory Board
Trade Union Secretary for the Management Board of IG Metall (until April 28, 2023)
Daniela Reinhardt*
Full-time Chairwoman of the Works Council of Kneipp GmbH (from April 28, 2023)
Wolfgang Röhrl*
Head of Plant and Product Development Incontinence Management segment PAUL HARTMANN AG
Representative of the executive staff
Joachim E. Schielke
Former Member of the Management Board of Landesbank Baden-Württemberg and former Chairman of the Management Board of Baden-Württembergische Bank (until April 28, 2023)
Eduard Schleicher
Managing Partner of SCHWENK Zement GmbH & Co. KG
Heide Schnare*
Trade Union Secretary for the Management Board of IG Metall (from April 28, 2023)
Thomas Spannagl
Managing Director of SCHWENK Baustoffgruppe, SCHWENK Zement GmbH & Co. KG (from April 28, 2023)
Prof. Dr. med. Sevgi Tercanli
Specialist in gynecology and obstetrics in own private practice (until April 28, 2023)
Eva Maria van Pelt
Co-CEO of Eppendorf SE (until 10. October 2023) (from April 28, 2023)
* Elected employee representatives
